These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
678 related items for PubMed ID: 15243924
21. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ. Clin Infect Dis; 2007 May 01; 44(9):1229-34. PubMed ID: 17407044 [Abstract] [Full Text] [Related]
22. Provirus load is lower in human T lymphotropic virus (HTLV)-II carriers than in HTLV-I carriers: a key difference in viral pathogenesis? Hisada M, Miley WJ, Biggar RJ. J Infect Dis; 2005 Apr 15; 191(8):1383-5; author reply 1385-6. PubMed ID: 15776392 [No Abstract] [Full Text] [Related]
23. Post-transfusional human retrovirus infection in 41 Italian beta-thalassemic patients. Aglianò AM, Vania A, Gandini O, Gradilone A, Napolitano M, Albonici L, Falconieri P, Digilio G, Manzari V, Frati L. Haematologica; 1992 Apr 15; 77(1):54-9. PubMed ID: 1398283 [Abstract] [Full Text] [Related]
24. Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I. Okayama A, Stuver S, Iga M, Okamoto M, Mueller N, Matsuoka M, Yamaguchi K, Tachibana N, Tsubouchi H. J Infect Dis; 2001 Apr 01; 183(7):1031-7. PubMed ID: 11237827 [Abstract] [Full Text] [Related]
25. Prevalence of human T-cell leukemia virus types I and II in Switzerland. Böni J, Bisset LR, Burckhardt JJ, Joller-Jemelka HI, Bürgisser P, Perrin L, Gorgievski M, Erb P, Fierz W, Piffaretti JC, Schüpbach J, Swiss HIV Cohort Study. J Med Virol; 2004 Feb 01; 72(2):328-37. PubMed ID: 14695678 [Abstract] [Full Text] [Related]
26. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique. Gudo ES, Abreu CM, Mussá T, Augusto Ado R, Otsuki K, Chambo E, Amade N, Tanuri A, Ferreira OC, Jani IV, HTLV in Mozambique Study Group. Transfusion; 2009 Jun 01; 49(6):1146-50. PubMed ID: 19222818 [Abstract] [Full Text] [Related]
27. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province]. Wang HR, Yan YS, Zhang QW, Zheng J, Liu JM, Feng YY, Wu SQ, Wu JH. Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May 01; 25(5):428-30. PubMed ID: 15231172 [Abstract] [Full Text] [Related]
29. Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians. Cimarelli A, Duclos CA, Gessain A, Cattaneo E, Casoli C, Biglione M, Mauclère P, Bertazzoni U. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct 01; 10(2):198-204. PubMed ID: 7552486 [Abstract] [Full Text] [Related]
31. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids. Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T. Invest Ophthalmol Vis Sci; 1997 Mar 01; 38(3):676-89. PubMed ID: 9071222 [Abstract] [Full Text] [Related]
33. Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects. Usadi B, Bruhn R, Lin J, Lee TH, Blackburn E, Murphy EL. Viruses; 2016 Aug 11; 8(8):. PubMed ID: 27529270 [Abstract] [Full Text] [Related]
34. [Molecular characterization of HTLV-II from an intravenous drug addict with AIDS in Argentina]. Biglione M, Avila MM, Biglione J, Weisburd G, Libonatti O, Gessain A. Rev Argent Microbiol; 1996 Aug 11; 28(3):139-42. PubMed ID: 9026824 [Abstract] [Full Text] [Related]
35. Stable human T-cell lymphotropic virus type 1 (HTLV-1) subtype a/subgroup a endemicity in Amerindians from Northwest Argentina: a health problem to be resolved. Eirin ME, Berini CA, Jones LR, Dilernia DA, Puca AA, Biglione MM. J Med Virol; 2010 Dec 11; 82(12):2116-22. PubMed ID: 20981802 [Abstract] [Full Text] [Related]
36. Molecular analysis of HTLV-I and HTLV-II isolates from Italian blood donors, intravenous drug users and prisoners. Ferrante P, Mancuso R, Zuffolato R, Puricelli S, Mannella E, Romanò L, Zanetti A, Cattaneo E, Corrao V. New Microbiol; 1997 Apr 11; 20(2):93-104. PubMed ID: 9208419 [Abstract] [Full Text] [Related]
37. Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. Maloney EM, Yamano Y, Vanveldhuisen PC, Sawada T, Kim N, Cranston B, Hanchard B, Jacobson S, Hisada M. J Infect Dis; 2006 Sep 01; 194(5):552-60. PubMed ID: 16897651 [Abstract] [Full Text] [Related]
38. Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens. Vallejo A, García-Sáiz A. J Virol Methods; 1995 Jan 01; 51(1):9-17. PubMed ID: 7730441 [Abstract] [Full Text] [Related]
40. Human T-cell lymphotropic virus type 1 provirus and phylogenetic analysis in patients with mycosis fungoides and their family relatives. Shohat M, Shohat B, Mimouni D, Pauli G, Ellerbrok H, David M, Hodak E. Br J Dermatol; 2006 Aug 01; 155(2):372-8. PubMed ID: 16882177 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]